Phase II Study Of SKI-606 [bosutinib] In Subjects With Advanced Or Metastatic Breast Cancer.

Trial Profile

Phase II Study Of SKI-606 [bosutinib] In Subjects With Advanced Or Metastatic Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Jan 2013

At a glance

  • Drugs Bosutinib (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 Feb 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
    • 08 Apr 2009 Planned number of patients changed from 60 to 75 as reported by ClinicalTrials.gov.
    • 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top